ESROKAST-M Tablets contain Doxofylline (Sustained Release) and Montelukast Sodium, providing effective relief from bronchial asthma, chronic bronchitis, and respiratory allergies. This combination relaxes airway muscles, reduces inflammation, and helps prevent asthma attacks. Each tablet contains Doxofylline (SR) [strength to be confirmed] and Montelukast Sodium IP [strength to be confirmed]. Pack size: 10 × 10 tablets. MRP: ₹149/-.
Dosage: Adults – 1 tablet once or twice daily as prescribed. Children – dose as advised by the physician.
Benefits:
Relieves breathing difficulties in asthma and bronchitis
Reduces airway inflammation and allergy symptoms
Prevents nocturnal asthma attacks
Sustained release for long-lasting effect
Convenient oral dosage
Why Choose Esroford Pharma: WHO-GMP certified manufacturing, clinically proven formulations, affordable pricing, wide distribution network, and trusted brand reputation.
